APOL6
Apolipoprotein L6
Also known as: APOL-VI, APOL6_HUMAN, APOLVI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BWW8
- Gene
- APOL6
- Ensembl
- ENSG00000221963
- Chromosome
- 22
- Canonical length
- 343 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies,Cytosol
OverviewNCBI Gene
This gene is a member of the apolipoprotein L gene family. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids or allow the binding of lipids to organelles. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
343 residues, UniProt reviewed canonical sequence.
>Q9BWW8|APOL6
1 MDNQAERESE AGVGLQRDED DAPLCEDVEL QDGDLSPEEK IFLREFPRLK EDLKGNIDKL
61 RALADDIDKT HKKFTKANMV ATSTAVISGV MSLLGLALAP ATGGGSLLLS TAGQGLATAA
121 GVTSIVSGTL ERSKNKEAQA RAEDILPTYD QEDREDEEEK ADYVTAAGKI IYNLRNTLKY
181 AKKNVRAFWK LRANPRLANA TKRLLTTGQV SSRSRVQVQK AFAGTTLAMT KNARVLGGVM
241 SAFSLGYDLA TLSKEWKHLK EGARTKFAEE LRAKALELER KLTELTQLYK SLQQKVRSRA
301 RGVGKDLTGT CETEAYWKEL REHVWMWLWL CVCLCVCVYV QFTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against APOL6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- liver: 44 nTPM
- adipose tissue: 22 nTPM
- small intestine: 19 nTPM
- duodenum: 18 nTPM
- spleen: 17 nTPM
- bone marrow: 15 nTPM
Single-cell type
- hepatocytes: 155 nCPM
- adipocytes: 142 nCPM
- nk-cells: 121 nCPM
- alveolar cells type 1: 104 nCPM
- enterocytes: 103 nCPM
- foveolar cells: 94 nCPM
Immune cell
- non-classical monocyte: 8.6 nTPM
- intermediate monocyte: 7.6 nTPM
- basophil: 7.5 nTPM
- neutrophil: 7.5 nTPM
- gdT-cell: 7.3 nTPM
- MAIT T-cell: 6.1 nTPM
Brain region
- medulla oblongata: 24 nTPM
- spinal cord: 19 nTPM
- pons: 17 nTPM
- white matter: 16 nTPM
- thalamus: 16 nTPM
- midbrain: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 0
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APOL6 as an antibody target. Whether an autoantibody or antibody against APOL6 could matter depends on whether native APOL6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APOL6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APOL6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...